Arthritis

The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.

Previous studies have suggested that a drug indicated for treating rheumatoid arthritis may increase the risk for blood clots. In a new study, researchers assessed this risk further.

Previous studies have suggested that a drug indicated for treating rheumatoid arthritis may increase the risk for blood clots. In a new study, researchers assessed this risk further.

Expansion of therapeutic possibilities for psoriatic arthritis have highlighted the need to identify residual disease and opportunities to adjust treatment.

In a recent study, researchers assessed trends in osteoporosis care in RA patients over the past decade.

Researchers analyzed data from the Framingham offspring cohort to determine if there is a relationship between metabolic syndrome and hand osteoarthritis.

A recent study examined the prevalence of and risk factors associated with enthesitis in patients with psoriatic arthritis.

Researchers have identified a biomarker linked to early-stage osteoarthritis and rheumatoid arthritis.

Rheumatologists and oncologists should work together to develop treatment plans for patients with cancer experiencing inflammatory responses from immune checkpoint inhibitors.